National Institute of Allergy and Infectious Diseases; Notice of Meetings, 78982-78983 [2013-31048]

Download as PDF 78982 Federal Register / Vol. 78, No. 249 / Friday, December 27, 2013 / Notices Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: John C Pugh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435– 2398, pughjohn@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: December 23, 2013. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–31051 Filed 12–26–13; 8:45 am] BILLING CODE 4140–01–P applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: http:// deainfo.nci.nih.gov/advisory/fac/fac.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 20, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2013–30890 Filed 12–26–13; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the NCIFrederick Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. tkelley on DSK3SPTVN1PROD with NOTICES National Cancer Institute; Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: NCI-Frederick Advisory Committee. Date: February 4, 2014. Time: 9:00 a.m. to 12:00 p.m. Agenda: Ongoing and New Activities at the Frederick National Laboratory for Cancer Research. Place: National Institutes of Health, 45 Center Drive, Natcher Building; Conference Room E1/E2, Bethesda, MD 20892. Contact Person: Thomas M. Vollberg, Sr., Ph.D., Executive Secretary, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 7W–102, Bethesda, MD 20892, 240–276–6341, vollbert@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when VerDate Mar<15>2010 23:48 Dec 26, 2013 Jkt 232001 National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel, December 11, 2013, 08:30 a.m., National Institutes of Health, Two Democracy Plaza, Suite 951, 6707 Democracy Boulevard, Bethesda, MD 20892, which was published in the Federal Register on August 29, 2013, 78 FR 64506. The meeting notice is amended to change the date and time from December 11, 2013, 08:30 a.m.–05:00 p.m., to January 9, 2014, 08:00 a.m.– 08:00 p.m. The meeting is closed to the public. Dated: December 20, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–30892 Filed 12–26–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00173 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the AIDS Research Advisory Committee, NIAID. The meetings will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: AIDS Research Advisory Committee, NIAID. Date: *January 27, 2014. Time: 1:00 p.m. to 5:00 p.m. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892. Contact Person: Mark A. Mueller, Executive Secretary, AIDS Research Advisory Committee, Division of AIDS, NIAID/NIH, Bethesda, MD 20892. 301–402–2308, mark.mueller@nih.gov. Name of Committee: AIDS Research Advisory Committee, NIAID. Date: June 2 2014. Time: 1:00 p.m. to 5:00 p.m. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892. Contact Person: Mark A. Mueller, Executive Secretary, AIDS Research Advisory Committee, Division of AIDS, NIAID/NIH, Bethesda, MD 20892. 301–402–2308, mark.mueller@nih.gov. Name of Committee: AIDS Research Advisory Committee, NIAID. Date: September 15, 2014. Time: 1:00 p.m. to 5:00 p.m. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892. Contact Person: Mark A. Mueller, Executive Secretary, AIDS Research Advisory Committee, Division of AIDS, NIAID/NIH, Bethesda, MD 20892. 301–402–2308, mark.mueller@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance E:\FR\FM\27DEN1.SGM 27DEN1 Federal Register / Vol. 78, No. 249 / Friday, December 27, 2013 / Notices onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and ransplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 20, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–31048 Filed 12–26–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meeting tkelley on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Bacterial Transcription and Regulation. Date: January 3, 2014. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Dominique Lorang-Leins, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Room 5108, MSC 7766, Bethesda, MD 20892, 301.326.9721, Lorangd@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) VerDate Mar<15>2010 23:48 Dec 26, 2013 Jkt 232001 78983 Dated: December 20, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2013–30891 Filed 12–26–13; 8:45 am] Office of the Director, National Institutes of Health; Notice of Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; NINDS Clinical Trial Methods Course. Date: January 9, 2014. Time: 12:00 p.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Ernest W Lyons, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS, NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892– 9529, lyonse@ninds.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: December 23, 2013. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–31052 Filed 12–26–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00174 Fmt 4703 Sfmt 4703 National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the Council of Councils. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Council of Councils. Open: January 31, 2014. Time: 9:45 a.m. to 12:00 p.m. Agenda: Council Business Matters and Updates; NIH Update. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892. Closed: January 31, 2014. Time: 12:00 p.m. to 1:00 p.m. Agenda: Review of grant applications. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892. Open: January 31, 2014. Time: 1:00 p.m. to 4:40 p.m. Agenda: Updates on Phase 2 Common Fund Planning. Report from Common Fund Science of Behavior Change Program. Update on Common Fund Planning and Management Working Group. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892. Contact Person: Franziska Grieder, DVM, Ph.D., Executive Secretary, Director, Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 6701 Democracy Boulevard, Room 948, Bethesda, MD 20892, 301–435–0744. Any interested person may file written comments with the committee by forwarding E:\FR\FM\27DEN1.SGM 27DEN1

Agencies

[Federal Register Volume 78, Number 249 (Friday, December 27, 2013)]
[Notices]
[Pages 78982-78983]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-31048]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the AIDS 
Research Advisory Committee, NIAID.
    The meetings will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: AIDS Research Advisory Committee, NIAID.
    Date: *January 27, 2014.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Mark A. Mueller, Executive Secretary, AIDS 
Research Advisory Committee, Division of AIDS, NIAID/NIH, Bethesda, 
MD 20892. 301-402-2308, mark.mueller@nih.gov.

    Name of Committee: AIDS Research Advisory Committee, NIAID.
    Date: June 2 2014.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Mark A. Mueller, Executive Secretary, AIDS 
Research Advisory Committee, Division of AIDS, NIAID/NIH, Bethesda, 
MD 20892. 301-402-2308, mark.mueller@nih.gov.

    Name of Committee: AIDS Research Advisory Committee, NIAID.
    Date: September 15, 2014.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Mark A. Mueller, Executive Secretary, AIDS 
Research Advisory Committee, Division of AIDS, NIAID/NIH, Bethesda, 
MD 20892. 301-402-2308, mark.mueller@nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance

[[Page 78983]]

onto the NIH campus. All visitor vehicles, including taxicabs, 
hotel, and airport shuttles will be inspected before being allowed 
on campus. Visitors will be asked to show one form of identification 
(for example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and ransplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 20, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-31048 Filed 12-26-13; 8:45 am]
BILLING CODE 4140-01-P